Zobrazeno 1 - 10
of 2 904
pro vyhledávání: '"donor lymphocyte infusion"'
Autor:
Esther Choi, BS, Cuong V. Nguyen, MD
Publikováno v:
JAAD Case Reports, Vol 52, Iss , Pp 42-45 (2024)
Externí odkaz:
https://doaj.org/article/c328054274a048bab92adc7b39b774c4
Publikováno v:
Asian Journal of Transfusion Science, Vol 18, Iss 1, Pp 124-127 (2024)
Donor lymphocyte infusions (DLIs) are often recommended products after allogeneic hematopoietic stem cell transplant to increase graft – versus – leukemia effect. More success rate of DLI has been reported in relapsed posttransplant chronic myelo
Externí odkaz:
https://doaj.org/article/3e84de71a16d41b7956fb0355ef96b6f
Autor:
Yi-Lun Wang, Tsung-Yen Chang, Yu-Chuan Wen, Shu-Ho Yang, Yi-Wen Hsiao, Chia-Chi Chiu, Yu-Chieh Chen, Ruei-Shan Hu, Shih-Hsiang Chen, Tang-Her Jaing, Chih-Cheng Hsiao
Publikováno v:
Hematology Reports, Vol 16, Iss 2, Pp 347-353 (2024)
Background/Objectives: Relapsed B-cell acute lymphoblastic leukemia (B-ALL) remains an unresolved matter of concern regarding adverse outcomes. This case study aimed to evaluate the effectiveness of blinatumomab, with or without door lymphocyte infus
Externí odkaz:
https://doaj.org/article/17a0e9cbc111478b9c38291dcd7e97af
Autor:
Martina Canichella, Paolo de Fabritiis
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1721 (2024)
Allogeneic stem cell transplant (ASCT) remains the only treatment option for patients with high-risk acute myeloid leukemia (AML). Recurrence of leukemic cells after ASCT represents a dramatic event associated with a dismal outcome, with a 2-year sur
Externí odkaz:
https://doaj.org/article/f758eb2ec554407aabd528d6ea93feac
Autor:
Flavia Antonucci, Serena Marotta, Maria Celentano, Mariangela Pedata, Cira Riccardi, Cristina Luise, Angela Carobene, Simona Maria Muggianu, Assunta Viola, Mafalda Caputo, Stefania Leone, Ilaria Migliaccio, Barbara Pocali, Mirella Alberti, Claudio Falco, Mario Toriello, Felicetto Ferrara, Alessandra Picardi
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
To date, the effect of blinatumomab and donor lymphocyte infusion association as a salvage treatment for acute lymphoblastic leukemia (ALL) relapse after allogeneic transplant procedure is still unknown. Here, we report a case report of a patient wit
Externí odkaz:
https://doaj.org/article/696d4a34f3cc49e0827dfbf48df98890
Autor:
Katie Maurer, Joseph H. Antin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for many hematologic malignancies as well as non-malignant conditions. Part of the curative basis underlying HSCT for hematologic malignancies relies upon ind
Externí odkaz:
https://doaj.org/article/76ab829b39e94e9b922ff43535853bda
Autor:
Eva A. S. Koster, Peter A. von dem Borne, Peter van Balen, Erik W. A. Marijt, Jennifer M. L. Tjon, Tjeerd J. F. Snijders, Daniëlle van Lammeren, Hendrik Veelken, J. H. Frederik Falkenburg, Constantijn J. M. Halkes, Liesbeth C. de Wreede
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionUnmodified donor lymphocyte infusions (DLI) after allogeneic stem cell transplantation (alloSCT) can boost the beneficial Graft-versus-Leukemia (GvL) effect but may also induce severe Graft-versus-Host-Disease (GvHD). To improve the balan
Externí odkaz:
https://doaj.org/article/f91495ebee1a4669a0b7b64a4d0daa90
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 640-644 (2023)
A woman in her forties with relapsed B-cell lymphoblastic lymphoma was treated with blinatumomab, but the drug proved ineffective. Salvage therapy with clofarabine induced a complete remission, and she received an allogeneic stem-cell transplantation
Externí odkaz:
https://doaj.org/article/6b58cd89497d4704a214750f1af2a9e4
Autor:
Eugenia Accorsi Buttini, Cristina Doran, Michele Malagola, Vera Radici, Marco Galli, Vicky Rubini, Alessandro Leoni, Mirko Farina, Nicola Polverelli, Federica Re, Simona Bernardi, Mohamad Mohty, Domenico Russo, Eolia Brissot
Publikováno v:
Cancers, Vol 16, Iss 7, p 1278 (2024)
Background: Disease relapse after allogeneic stem cell transplantation (allo-SCT) is the main challenge for curing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We investigated the overall survival (OS) after allo-SCT relapse accor
Externí odkaz:
https://doaj.org/article/447c69035031472387586346661736e1
Autor:
Danilo Martinovic, Justin Hasenkamp, Wolfram Jung, Frank Tucholski, Jens‐Holger Maas, Gerald Georg Wulf
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 563-565 (2023)
Externí odkaz:
https://doaj.org/article/fe760b0e9bdc49f389a2e530b6b52cba